Table 6. Cytological response.
| Studies | CRC patients | Evaluated patients | Total PIPAC-OX | Response assessment | ||
|---|---|---|---|---|---|---|
| Progressive | Stable | Regressive | ||||
| Ellebæk [2020] (17) | 24 | 15 | 75 | 2 | 8 | 5 |
| Graversen [2020] (19) | 3 | 3 | 9 | 0 | 2 | 1 |
CRC, colorectal cancer; PIPAC-OX, pressurized intraperitoneal aerosol chemotherapy with oxaliplatin.